Amanda Przespolewski
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 27, 2024
Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.Jeffrey Baron, Daniel Appiah, Mark G Faber
|Dec 09, 2022
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati
|Nov 25, 2021
Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches.Amanda C Przespolewski, Scott Portwood, Eunice S Wang
|Feb 17, 2021
Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy.Amanda Przespolewski, Monica R Muppidi, Craig W Freyer
|Oct 27, 2020
Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia.Craig W Freyer, Chelsea E Peterson, Yun Man
Pageof 1
Frequent Collaborators
2 joint publications
Craig W Freyer
2 joint publications
Jeffrey Baron
2 joint publications
Elizabeth A Griffiths
1 joint publications
Aaron D Goldberg
1 joint publications
Pankit Vachhani
1 joint publications
Swapna Thota
1 joint publications
Julian Waksal
1 joint publications
James E Thompson
1 joint publications
Daniel Appiah
1 joint publications
Jared Vega
